Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration.
- Resource Type
- Article
- Source
- Targeted Oncology; Nov2021, Vol. 16 Issue 6, p773-787, 15p
- Subject
- Language
- ISSN
- 17762596